FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Al-Nawas, B; Grotz, KA; Goetz, H et al.
Systematische qualitative Histologie von enossalen Implantaten mit anodisch oxidierten Oberflachen.Mund Kiefer Gesichtschir. Bd. 10. H. 4. 2006 S. 229-37
Dalken, B; Giesubel, U; Knauer, SK et al.
Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.Cell Death Differ. Bd. 13. H. 4. 2006 S. 576-85
Fottner, C; Helisch, A; Minnemann, T et al.
Targeted peptide receptor radionuclide for advanced neuroendocrine tumors (NET) with 90 Y-DOTATOC - tumor response and clinical benefit. 50th Annual Meeting of the German Society of EndocrinologyExp Diabesity Res. Bd. 114. 2006 S. P05-069
Schneider, T; Wolcke, B; Böhmer, R
Taschenatlas Notfall & Rettungsmedizin3. Aufl. Heidelberg: Springer 2006 300 S.
Böhmer, R; Schneider, T; Wolcke, B
Taschenatlas Rettungsdienst6. Aufl. Mainz: Naseweis 2006 605 S.
Mann, WJ; Gosepath, J
Technical Note: minimal access surgery for cochlear implantation with MED-EL devices.ORL J Otorhinolaryngol Relat Spec. Bd. 68. H. 5. 2006 S. 270-2
Krämer, I
Temsirolimus - der érste zur antineoplastischen Therapie zuglassene mTor-AntagonistKrankenhauspharmazie. Bd. 2. 2006 S. 55-60
Müller, M; Meyer, M; Schilling, T et al.
Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.Int J Oncol. Bd. 29. H. 4. 2006 S. 973-80
Bockamp, Ernesto; Antunes, Cecilia; Maringer, Marko et al.
Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cellsBLOOD. Bd. 108. H. 5. 2006 S. 1533-1541